Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Clinical Drug Investigation|April 4, 2019
Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?Florenzo Iannone, Angelo Semeraro, Giorgio Carlino, et al.
Clinical Rheumatology|February 11, 2015
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialistsLuca Cantarini, Antonio Vitale, Giulia Bersani, et al.
Journal of Clinical Medicine|December 23, 2022
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium"Fausto Salaffi, Cesare Siragusano, Alessandra Alciati, et al.
Clinical and Experimental Rheumatology|April 18, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registryMarco Fornaro, Roberto Caporali, Martina Biggioggero, et al.
Mediators of Inflammation|August 19, 2014
Untangling the web of systemic autoinflammatory diseasesDonato Rigante, Giuseppe Lopalco, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|February 16, 2019
Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEAFabiola Atzeni, Piercarlo Sarzi-Puttini, Marco Sebastiani, et al.
Clinical Rheumatology|February 22, 2018
Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)Florenzo Iannone, Leonardo Santo, Romano Bucci, et al.
Clinical Rheumatology|March 25, 2014
Serum amyloid-A in Behçet's diseaseAntonio Vitale, Donato Rigante, Giuseppe Lopalco, et al.
Clinical Rheumatology|February 8, 2018
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE)Florenzo Iannone, Leonardo Santo, Romano Bucci, et al.
Clinical and Experimental Rheumatology|May 23, 2014
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritisAntonio Spadaro, Ennio Lubrano, Antonio Marchesoni, et al.
Pageof 12